Insiders Updates
JP Morgan downgrades Atea Pharmaceuticals Inc (AVIR) rating to an Underweight
Atea Pharmaceuticals Inc’s recent filing unveils that its Director Polsky Bruce unloaded Company’s shares for reported $61144.0 on Jun 20
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.